Millipore Sigma Vibrant Logo

681535 Withaferin A, Withania somnifera - CAS 5119-48-2 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
5119-48-2C₂₈H₃₈O₆

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
681535-1MG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Kst.-Ampulle 1 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      681535-5MG
      Verfügbarkeit wird abgerufen...
      Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
      Lieferbar 
      Produkt wurde eingestellt
      Begrenzter Lagerbestand
      Bestätigung der Verfügbarkeit erforderlich
        Restmenge: Angebot folgt
          Restmenge: Angebot folgt
          Bitte erfragen
          Kontakt zum Kundenservice
          Contact Customer Service

          Kst.-Ampulle 5 mg
          Preis wird abgerufen...
          Preis nicht abrufbar
          Die Mindestmenge muss ein Vielfaches sein von
          Maximum Quantity is
          Bei Bestätigung Weitere Informationen
          Sie haben () gespart
           
          Bitte erfragen
          Description
          OverviewA cell-permeable steroidal lactone that displays antitumor, anti-inflammatory, radiosensitizing, and immunosuppressive properties. Potently inhibits angiogenesis both in vitro (IC50 = 12 nM against HUVEC proliferation) and in vivo (80% inhibition at 7 µg/kg/day in C57BL/6J mice, s.c.) and NF-κB activation (IC50 = 500 nM in TNF-α-induced endothelial cells) by targeting the ubiquitin-mediated proteasome pathway. At higher concentrations (~5 µM) also affects AP-1 transcription and induces cell death.
          Catalogue Number681535
          Brand Family Calbiochem®
          References
          ReferencesMohan, R., et al. 2004. Angiogenesis 7, 115.
          Jeyaprakasam, B., et al. 2003. Life Sci. 74, 125.
          Devi, P.U., et al. 1995. Cancer Lett. 95, 189.
          Kupchan, S.M., et al. 1969. J. Org. Chem. 34, 3858.
          Product Information
          CAS number5119-48-2
          ATP CompetitiveN
          FormWhite solid
          Hill FormulaC₂₈H₃₈O₆
          Chemical formulaC₂₈H₃₈O₆
          ReversibleN
          Structure formula ImageStructure formula Image
          Quality LevelMQ100
          Applications
          Biological Information
          Primary TargetA steroidal lactone that displays antitumor, anti-inflammatory, radiosensitizing, and immunosuppressive properties.
          Primary Target IC<sub>50</sub>12 nM against angiogenesis in vitro by inhibiting HUVEC proliferation
          Purity≥94% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECSKE7288500
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
          Toxicity Carcinogenic / Teratogenic
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Bestellnummer GTIN
          681535-1MG 04055977260113
          681535-5MG 04055977260120

          Documentation

          Withaferin A, Withania somnifera - CAS 5119-48-2 - Calbiochem SDB

          Titel

          Sicherheitsdatenblatt (SDB) 

          Withaferin A, Withania somnifera - CAS 5119-48-2 - Calbiochem Analysenzertifikate

          TitelChargennummer
          681535

          Literatur

          Übersicht
          Mohan, R., et al. 2004. Angiogenesis 7, 115.
          Jeyaprakasam, B., et al. 2003. Life Sci. 74, 125.
          Devi, P.U., et al. 1995. Cancer Lett. 95, 189.
          Kupchan, S.M., et al. 1969. J. Org. Chem. 34, 3858.
          Datenblatt

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision16-September-2008 RFH
          DescriptionA cell-permeable steroidal lactone that displays antitumor, anti-inflammatory, radiosensitizing, and immunosuppressive properties. Potently inhibits angiogenesis both in vitro (IC50 = 12 nM against HUVEC proliferation) and in vivo (80% inhibition at 7 µg/kg/day in C57BL/6J mice, s.c.) and NF-κB activation (IC50 = 500 nM in TNF-α-induced endothelial cells) by targeting the ubiquitin-mediated proteasome pathway. At higher concentrations (~5 µM) also affects AP-1 transcription and induces cell death.
          FormWhite solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number5119-48-2
          RTECSKE7288500
          Chemical formulaC₂₈H₃₈O₆
          Structure formulaStructure formula
          Purity≥94% by HPLC
          SolubilityDMSO (10 mg/ml) or Ethanol (5 mg/ml)
          Storage Protect from light
          +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Carcinogenic / Teratogenic
          ReferencesMohan, R., et al. 2004. Angiogenesis 7, 115.
          Jeyaprakasam, B., et al. 2003. Life Sci. 74, 125.
          Devi, P.U., et al. 1995. Cancer Lett. 95, 189.
          Kupchan, S.M., et al. 1969. J. Org. Chem. 34, 3858.